Scholarlink

Background <p>Acute myeloid leukemia (AML) occasionally presents with extramedullary disease, but pulmonary involvement is rare and often misdiagnosed as primary lung carcinoma, particularly in chronic smokers. Accurate diagnosis requires histopathology supplemented by immunohistochemistry (IHC).</p> Case presentation <p>We report a 70-year-old chronic smoker who presented with cough, chest pain, weight loss, and a right hilar lung mass. Initial histology of a lung biopsy was suspicious for small-cell lung carcinoma (SCLC). However, laboratory findings revealed progressive cytopenias and circulating blasts. Bone marrow evaluation demonstrated florid myeloblast proliferation consistent with AML. Further IHC of the lung biopsy confirmed myeloid lineage (CD34 positivity, MPO, CD117) and excluded neuroendocrine or epithelial carcinoma markers (TTF-1, synaptophysin, chromogranin, cytokeratin AE1/AE3). A final diagnosis of AML with pulmonary involvement was established. Despite diagnosis, the patient deteriorated rapidly and died before initiation of therapy.</p> Conclusion <p>This case highlights the diagnostic dilemma of AML masquerading as primary lung cancer in smokers. It underscores the indispensable role of IHC in distinguishing hematologic malignancies from solid tumors, thereby avoiding misdiagnosis and inappropriate management. Clinicians should maintain a high index of suspicion for hematologic disease when atypical laboratory findings accompany pulmonary masses.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acute myeloid leukemia presenting as a pulmonary mass in a 70-year-old: a diagnostic challenge

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月6日

查看全文
  • A. A. Oladeji,
  • A. M. Folasire,
  • F. O. Sarimiye,
  • M. A. Ajani,
  • B. O. Edijana

摘要

Background

Acute myeloid leukemia (AML) occasionally presents with extramedullary disease, but pulmonary involvement is rare and often misdiagnosed as primary lung carcinoma, particularly in chronic smokers. Accurate diagnosis requires histopathology supplemented by immunohistochemistry (IHC).

Case presentation

We report a 70-year-old chronic smoker who presented with cough, chest pain, weight loss, and a right hilar lung mass. Initial histology of a lung biopsy was suspicious for small-cell lung carcinoma (SCLC). However, laboratory findings revealed progressive cytopenias and circulating blasts. Bone marrow evaluation demonstrated florid myeloblast proliferation consistent with AML. Further IHC of the lung biopsy confirmed myeloid lineage (CD34 positivity, MPO, CD117) and excluded neuroendocrine or epithelial carcinoma markers (TTF-1, synaptophysin, chromogranin, cytokeratin AE1/AE3). A final diagnosis of AML with pulmonary involvement was established. Despite diagnosis, the patient deteriorated rapidly and died before initiation of therapy.

Conclusion

This case highlights the diagnostic dilemma of AML masquerading as primary lung cancer in smokers. It underscores the indispensable role of IHC in distinguishing hematologic malignancies from solid tumors, thereby avoiding misdiagnosis and inappropriate management. Clinicians should maintain a high index of suspicion for hematologic disease when atypical laboratory findings accompany pulmonary masses.